RESEARCH PAPER
Serum levels of vitamin D, magnesium, calcium, iron, and total iron binding capacity in HIV-infected patients
More details
Hide details
1
Department of Infectious Diseases and Tropical Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
2
Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3
Department of Oral and Maxillofacial Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
4
Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
5
Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
Submission date: 2018-08-08
Acceptance date: 2018-09-14
Publication date: 2019-03-10
HIV & AIDS Review 2019;18(2):148-152
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Alterations of vitamins and minerals have been seen in patients with the human immune virus (HIV) in numerous studies. This study aimed to evaluate serum levels of vitamin D, magnesium, calcium, iron, and total iron binding capacity (TIBC) in HIV-infected patients compared with controls in western Iran.
Material and methods:
Ninety-eight HIV-infected prisoners and 98 healthy controls were selected for the study in 2016. Cluster of differentiation 4 (CD4) was checked in all HIV-infected patients. Age, sex, vitamin D, calcium, magnesium, iron, and TIBC were checked for each person in both groups.
Results:
The mean age (range) of the HIV-infected and the healthy control groups was 40.11 years (21-68 years) and 45.59 (18-85 years), respectively. Vitamin D, calcium, iron and TIBC levels were significantly different in the two groups. There was a significant correlation between calcium and iron levels and the CD4 count.
Conclusions:
There were significant differences in vitamin D, calcium, iron, and TIBC levels in the HIV-infected patients compared to the healthy controls. Therefore, the results show the correlation between these levels and the incidence of HIV. In addition, the significant difference between calcium and iron levels with the CD4 counts can enhance the correlation.
REFERENCES (29)
1.
Kharb S, Kumawat M, Lallar M, et al. Serum iron, Folate, Ferritin and CD4 Count in HIV Seropositive Women. Indian J Clin Biochem 2017; 32: 95-98.
2.
Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet 2014; 384: 258-271.
3.
Bagheri Amiri F, Mostafavi E, Mirzazadeh A. HIV, HBV and HCV Coinfection Prevalence in Iran – A Systematic Review and Meta-Analysis. PLoS One 2016; 11: e0151946.
4.
Fettig J, Swaminathan M, Murrill CS, et al. Global epidemiology of HIV. Infect Dis Clin North Am 2014; 28: 323-337.
5.
Pinzone MR, Di Rosa M, Malaguarnera M, et al. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci 2013; 17: 1218-1232.
6.
Meyzer C, Frange P, Chappuy H, et al. Vitamin D deficiency and insufficiency in HIV-infected children and young adults. Pediatr Infect Dis J 2013; 32: 1240-1244.
7.
Yin M. Vitamin D, bone, and HIV infection. Top Antivir Med 2012; 20: 168-172.
8.
Dao CN, Patel P, Overton ET, et al. Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52: 396-405.
9.
Teichmann J, Stephan E, Lange U, et al. Elevated serum-calcium and parathormone-levels in HIV afflicted female heroin addicts. Eur J Med Res 1997; 2: 343-346.
10.
Tolentino K, Friedman JF. An update on anemia in less developed countries. Am J Trop Med Hyg 2007; 77: 44-51.
11.
Wisaksana R, Sumantri R, Indrati AR, et al. Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis 2011; 11: 213.
12.
Fazlini MF, Suriah AR, Zaitun Y, et al. Calcium supplementation amongst postmenopausal women: effect on serum calcium, phosphorus and magnesium levels. Int Food Res J 2013; 20: 477-480.
13.
van Vonderen MG, Lips P, van Agtmael MA, et al. First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS 2009; 23: 1367-1376.
14.
Hovsepian S, Amini M, Aminorroaya A, et al. Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran. J Health Popul Nutr 2011; 29: 149-155.
15.
Mansueto P, Seidita A, Vitale G, et al. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. Biomed Res Int 2015; 2015: 735615.
16.
Eckard AR, Tangpricha V, Seydafkan S, et al. The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults. Pediatr Infect Dis J 2013; 32: 1224-1229.
17.
Conesa-Botella A, Florence E, Lynen L, et al. Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 2010; 7: 40.
18.
Kuehn EW, Anders HJ, Bogner JR, et al. Hypocalcaemia in HIV infection and AIDS. J Intern Med 1999; 245: 69-73.
19.
Shadrack BE, Digban KA, Ishiaku AA, et al. Serum Calcium Level in HIV Patients at Federal Medical Center Yenagoa, Bayelsa State, Nigeria. Int J Sci Res 2014; 3: 507-510.
20.
Afridi HI, Kazi TG, Talpur FN, et al. Evaluation of calcium, magnesium, potassium and sodium in biological samples of male human immunodeficiency virus patients with tuberculosis and diarrhea compared to healthy control subjects in Pakistan. Clin Lab 2013; 59: 539-550.
21.
Paccou J, Viget N, Legrout-Gérot I, et al. Bone loss in patients with HIV infection. Joint Bone Spine 2009; 76: 637-641.
22.
Banjoko SO, Oseni FA, Togun RA, et al. Iron status in HIV-1 infection: implications in disease pathology. BMC Clin Pathol 2012; 12: 26.
23.
Salhi Y, Costagliola D, Rebulla P, et al. Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 473-478.
24.
Chung M, Lee J, Terasawa T, et al. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. preventive services task force. Ann Intern Med 2011; 155: 827-838.
25.
Obum-Nnadi CN, Nathaniel O, Mbata TI, et al. Assay of the Level of Calcium, Magnesium and Inorganic Phosphorus in HIV Infected Patients in Owerri, Southeast Nigeria. J Clin Exp Pathol 2013; 3: 134.
26.
Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993; 328: 327-335.
27.
Haug CJ, Aukrust P, Lien E, et al. Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxy vitamin D. J Infect Dis 1996; 173: 259-262.
28.
Haug C, Muller F, Aukrust P, et al. Subnormal serum concentration of 1,25-Vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J Infect Dis 1994; 169: 889-893.
29.
Isnard Bagnis C, Du Montcel ST, Fonfrede M, et al. Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era. Nephron Physiol 2006; 103: 131-138.